Researchers have discovered a protein called SEL1L that plays a critical role in clearing collagen from tissue, and which may be a therapeutic target to help prevent fibrosis, scar tissue that interferes with organ function.
An iron-binding drug that is already approved for treatment of other diseases could provide a novel way to attack ovarian tumors, according to a new study led by Weill Cornell Medicine researchers.
Weill Cornell Medicine scientists have uncovered the first evidence that astrocyte receptors can trigger opposite effects on cognitive function in male and female preclinical models.
Cornell Human Ecology faculty members Denise Green ’07 and Laura Bellows have recently been awarded fellowships in the Bronfenbrenner Center for Translational Research (BCTR).
A decline in estrogen during menopause causes changes in body fat distribution and associated cardiovascular and metabolic disease, but a new Cornell-led study identifies potential therapies that might one day reverse these unhealthy shifts.
With new funding from the National Institutes of Health (NIH), Cornell faculty will investigate how SBHCs are not only leaving a positive impact on students, but also on the wider community’s well-being and public services across four counties in upstate New York.
As French authorities face widespread reports of a bedbug infestation in Paris, Jody Gangloff-Kaufmann, a Cornell University entomologist whose work focuses on reducing pest risks, provides some tips of what to look for and how to salvage exposed belongings.
A new preclinical model offers a unique platform for studying the Parkinson’s disease process and suggests a relatively easy method for detecting the disease.
Marion Nestle, a food policy expert and public health advocate, will share her experience bridging research, policy and public engagement in a talk, “Food Politics: An Agenda for 2024.”
